J&J JNJ announced plans to invest more than $55 billion over the next four years to expand its manufacturing footprint in the ...

The FDA has approved Tremfya as the “first and only” interleukin-23 inhibitor that offers both IV and fully subcutaneous ...

The label expansion could help J&J establish Tremfya as a successor to Stelara, which is now facing a growing biosimilar ...

Celltrion Inc., a major South Korean biopharmaceutical firm, said Thursday it has launched its biosimilar product for Stelara, an autoimmune disease treatment, in the United States. Steqeyma, a ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

The study confirmed that YESINTEK matches Stelara (Ustekinumab) in effectiveness, safety, immune response, and drug behavior in the body. This marks a major step for Biocon Biologics in making ...

Lady Gaga is set to take on Chappell Roan for Number 1 this week – Abracadabra (2) is less than 1,400 chart units away from Pink Pony Club (1), which became the first UK chart-topper for pop ...

The Official Chart is turned into the Pink Pony Club today, as Chappell Roan finally secures her first UK Number 1 single. Pink Pony Club go-go dances to the top of the Official Singles Chart ...

If a language can be used to build web scrapers, it definitely needs to provide a graceful data visualization library. --- by dongdong. In the Golang ecosystem, there are not many choices for data ...

Otulfi demonstrated comparable efficacy, safety, pharmacokinetics and immunogenicity to the reference drug Stelara® in patients with moderate to severe plaque psoriasis. Otulfi was approved for ...

The FDA has provisionally determined that Otulfi ® will be interchangeable with the reference drug Stelara ®, following the expiration of a competitor’s interchangeability exclusivity.

Johnson & Johnson (JNJ) filed a suit against Samsung Bioepis for breach of contract related to the launch of a biosimilar of J&J's blockbuster drug Stelara, also known as ustekinumab. According to ...